A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer

<div>Comparisons of IR783-NanoBubble-Affibody and SonoVue in size distribution and morphology. Size distribution of IR783-NBs-Affibody (a) and SonoVue microbubbles (b). TEM images of IR783-NBs-Affibody (c) and SonoVue microbubbles (d).</div>

Journal of Immunology Research

fig1

Figure 1

Figure 1: A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer 